[SEOUL BIO HUB] Open Innovation with Daewon Pharmaceutical
- SD&K Holdings
- Sep 18, 2024
- 1 min read

We are pleased to share the news that SD&K is leading the Open Innovation Programme, supported by Seoul Bio Hub, for two bio-startups specialising in DDS (Drug Delivery Systems), in collaboration with Daewon Pharmaceutical.
As part of our exciting journey, we held an opening ceremony with Seoul Metropolitan City and KIST.
Media:

![[ChosunBiz] Exclusive Interview with Professor Sir David Klenerman](https://static.wixstatic.com/media/fc47c5_383020be65c84c848a50119def8f60d4~mv2.jpg/v1/fill/w_980,h_1470,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/fc47c5_383020be65c84c848a50119def8f60d4~mv2.jpg)

Comments